FDA
-
-
-
-
-
-
-
Beyond Air to Participate in the D. Boral Capital Global Conference 2026
-
-
-
-
-
-
-
Beyond Air to Participate in the 38th Annual Roth Conference in March
-
-
-
-
-
-
-
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026
-
-
-
-
-
-
-
XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary
-
-
-
-
-
-
-
Beyond AirĀ® Announces Transition of Chief Financial Officer
-
-
-
-
-
-
-
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
-
-
-
-
-
-
-
Beyond Air Schedules First Fiscal Quarter 2026 Financial Results Conference Call and Webcast
-
324,879 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

